gilead hiv drugs - Yahoo Search Results

Ads
related to: gilead hiv drugs
HCPs: Downloadable Resources - Healthcare Professional Site

www.dovatohcp.com
Attention HCPs - Learn More About DOVATO (dolutegravir/lamivudine) & View Boxed Warning. Explore A Resources Page To Find Answers To Your Questions About DOVATO.
Drug Interactions
Get Drug Interaction Info For Your

Patients & Sign Up For Updates.

Savings Info For Patients
Learn More About The Patient Access

& Savings Program For DOVATO.

Information For HCPs
Rethink Your Patients' Care By

Discovering More About DOVATO.

HCP Educational Resources
Download DHHS Guidelines And

View Full Prescribing Information.

Important Safety Info
View Important Safety Info As Well

As Potential Risks & Side Effects.

HCPs: Clinical Data
Review Info And Data From Several

Clinical Studies For DOVATO.
Are You HIV Positive? - Learn About A Treatment Option

www.treathiv1.com
Discover An HIV Treatment Option That May Help You Reach Undetectable. Learn More Now. Learn If You May Be Eligible To Save On Treatment. Visit The Official Patient Site Now.
Side Effects And Safety
Talking To Your Doctor
Learn How Treatment Works

Search results

- Gilead (GILD) Up on Settling HIV Drug Suit With Generic Players
  Zacks via Yahoo Finance· 2 years ago
  Gilead (GILD) enters settlement agreements with a few generic manufacturers to resolve the...
- FDA Approves Gilead's New HIV Treatment For Heavily Treated With Multi-Drug Resistant Patients
  Benzinga via Yahoo Finance· 1 year ago
  The FDA has approved Gilead Sciences Inc's (NASDAQ: GILD) Sunlenca (lenacapavir), in combination...
- Gilead vs. CDC: The $1B Showdown Over HIV Drug Profits
  Benzinga via Yahoo Finance· 1 year ago
  Gilead Sciences Inc (NASDAQ: GILD) is reportedly looking to fight claims that it owes the U.S....
- UPDATE 2-Gilead profit tops expectations despite lower COVID drug sales, outlook raised
  Reuters via Yahoo Finance· 2 years ago
  Gilead Sciences Inc on Thursday posted a higher-than-expected third-quarter profit on the back of...
- Gilead Sciences: The Bull Case Is More Powerful Than You Think
  GuruFocus.com via Yahoo Finance· 5 months ago
  Gilead Sciences Inc. (NASDAQ:GILD) is an American pharmaceutical company specializing in developing...
- Gilead expands FDA label for Biktarvy with Phase I pregnant HIV patient data
  Clinical Trials Arena via Yahoo Finance· 2 weeks ago
  The expanded approval of Gilead’s Biktarvy was based on the Phase I trial data showing efficacy in...
- Clinics are losing funding for HIV prevention drugs and screenings. Here's what that means
  Austin American-Statesman via Yahoo News· 12 months ago
  Preventing new HIV infections is becoming more difficult for nonprofit health clinics. Three things...
- Gilead to buy CymaBay for $4.3 billion in bets on liver disease treatment
  Reuters via Yahoo Finance· 3 months ago
  (Reuters) -Gilead Sciences has agreed to buy CymaBay Therapeutics for $4.3 billion, gaining access...
- Gilead (GILD) HIV Candidate Gets Positive CHMP Recommendation
  Zacks via Yahoo Finance· 2 years ago
  Gilead Sciences, Inc. GILD has announced that the Committee for Medicinal Products for Human Use...
- Gilead Sciences prevails in US government lawsuit over HIV drug patents
  Reuters via Yahoo Finance· 1 year ago
  A federal jury on Tuesday found that Gilead Sciences Inc did not infringe U.S. patents with its HIV-prevention regimen using the drugs Truvada and Descovy, handing the government a defeat in ...